HPV Vaccine Slashes Rates of Oral Infection

Cancer Discov. 2017 Jul;7(7):OF6. doi: 10.1158/2159-8290.CD-NB2017-074. Epub 2017 May 19.

Abstract

Vaccination against human papillomavirus (HPV) reduces the prevalence of oral infection by an estimated 88% among young adults in the United States, a protection that could help reduce rates of HPV-related oropharyngeal cancers, according to data that will be presented at the American Society of Clinical Oncology Annual Meeting in Chicago, IL. However, the population-level benefit will remain low unless more people get vaccinated.

MeSH terms

  • Female
  • Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 / therapeutic use*
  • Humans
  • Mouth / drug effects
  • Mouth / virology
  • Oropharyngeal Neoplasms / epidemiology
  • Oropharyngeal Neoplasms / prevention & control*
  • Oropharyngeal Neoplasms / virology
  • Papillomavirus Infections / epidemiology
  • Papillomavirus Infections / prevention & control*
  • Papillomavirus Infections / virology
  • Papillomavirus Vaccines / therapeutic use*
  • United States
  • Uterine Cervical Neoplasms / epidemiology
  • Uterine Cervical Neoplasms / prevention & control
  • Uterine Cervical Neoplasms / virology

Substances

  • Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
  • Papillomavirus Vaccines